Sagami Rubber Industries Co., Ltd. (JP:5194)
:5194
Top Page
Sagami Rubber Industries Co., Ltd.
(5194)
Select Model
Select Model
Rating:52Neutral
Price Target:
¥645.00
▼(-12.13% Downside)
Action:ReiteratedDate:11/18/25
The overall stock score of 52 reflects a stable financial structure but is weighed down by bearish technical indicators and poor valuation metrics. The company's challenges in revenue growth and profitability, combined with weak market sentiment, contribute to the lower score.
Positive Factors
Stable balance sheet / controlled leverage
A conservative leverage profile and a strong equity ratio provide durable financial flexibility, enabling the company to fund capital expenditure, maintain manufacturing capacity, and absorb demand volatility without reliance on costly external financing. This supports long-term operational resilience and strategic investments.
Negative Factors
Declining revenue trend
A multi-year decline in total revenue erodes scale advantages, reduces bargaining power on input costs, and raises per-unit fixed-cost burdens. Persistent top-line contraction can limit reinvestment capacity, undermine OEM and retail partnerships, and signal structural demand or share-loss issues over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable balance sheet / controlled leverage
A conservative leverage profile and a strong equity ratio provide durable financial flexibility, enabling the company to fund capital expenditure, maintain manufacturing capacity, and absorb demand volatility without reliance on costly external financing. This supports long-term operational resilience and strategic investments.
Read all positive factors
Sagami Rubber Industries Co., Ltd. (5194) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.94B
Dividend Yield1.37%
Average Volume (3M)9.14K
Price to Earnings (P/E)20.5
Beta (1Y)0.48
Revenue Growth-2.67%
EPS Growth-143.38%
CountryJP
Employees854
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)8.93
Shares Outstanding10,937,449
10 Day Avg. Volume11,640
30 Day Avg. Volume9,140
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.92
Price to Sales (P/S)1.75
P/FCF Ratio14.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sagami Rubber Industries Co., Ltd. Business Overview & Revenue Model
Company Description
Sagami Rubber Industries Co., Ltd. primarily manufactures and supplies condoms. The company offers polyurethane and latex condoms, external catheters, and probe covers; plastic films; and healthcare products and services. It sells its products in ...
How the Company Makes Money
Sagami Rubber Industries primarily makes money by selling manufactured sexual wellness products—most notably condoms—through a mix of branded sales and supply to other channels. Key revenue streams include (1) sales of the company’s own branded pr...
Sagami Rubber Industries Co., Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.02B | 5.69B | 6.11B | 5.98B | 5.41B | 5.59B |
| Gross Profit | 1.61B | 1.47B | 1.83B | 1.89B | 2.24B | 2.43B |
| EBITDA | 1.23B | 1.47B | 1.14B | 1.75B | 2.00B | 1.46B |
| Net Income | 175.89M | 392.54M | 40.96M | 673.52M | 1.10B | 598.05M |
Balance Sheet | ||||||
| Total Assets | 18.28B | 18.64B | 17.90B | 18.24B | 17.11B | 15.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.05B | 1.93B | 1.19B | 1.85B | 1.53B | 1.47B |
| Total Debt | 5.59B | 5.66B | 5.74B | 6.41B | 6.50B | 6.46B |
| Total Liabilities | 7.51B | 7.52B | 7.80B | 8.29B | 8.19B | 8.22B |
| Stockholders Equity | 10.51B | 10.84B | 9.84B | 9.66B | 8.66B | 7.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 693.67M | 241.52M | 711.94M | 230.31M | -753.05M |
| Operating Cash Flow | 0.00 | 790.28M | 373.60M | 898.87M | 905.32M | 1.41B |
| Investing Cash Flow | 0.00 | 438.49M | -133.05M | -184.86M | -675.76M | -2.16B |
| Financing Cash Flow | 0.00 | -503.15M | -906.58M | -422.13M | -189.90M | 671.23M |
Sagami Rubber Industries Co., Ltd. Technical Analysis
Neutral
734.00
Price Trends
652.69
Negative
701.91
Negative
804.90
Negative
Market Momentum
-5.74
Negative
46.68
Neutral
45.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5194, the sentiment is Neutral. The current price of 734 is above the 20-day moving average (MA) of 635.70, above the 50-day MA of 652.69, and below the 200-day MA of 804.90, indicating a neutral trend. The MACD of -5.74 indicates Negative momentum. The RSI at 46.68 is Neutral, neither overbought nor oversold. The STOCH value of 45.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:5194.
Sagami Rubber Industries Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.78T | 23.99 | 10.79% | 3.47% | -1.56% | -1.15% | |
76 Outperform | ¥452.43B | 16.53 | 9.09% | 1.73% | 2.18% | 60.81% | |
71 Outperform | ¥579.70B | 13.97 | 12.66% | 1.53% | 18.35% | 31.87% | |
70 Outperform | ¥2.81T | 24.05 | 11.50% | 2.41% | 4.62% | 47.68% | |
65 Neutral | ¥447.94B | 110.37 | 5.37% | 1.95% | -3.33% | 13.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | ¥6.94B | 20.55 | ― | 1.37% | -2.67% | -143.38% |
* Consumer Defensive Sector Average
JP:5194
Sagami Rubber Industries Co., Ltd.
639.00
-256.80
-28.67%
JP:4452
Kao
6,208.00
124.00
2.04%
JP:4967
Kobayashi Pharmaceutical Co
6,040.00
703.51
13.18%
JP:4912
Lion
1,667.00
-96.66
-5.48%
JP:4527
Rohto Pharmaceutical Co
2,497.00
166.94
7.16%
JP:8113
Unicharm
973.00
-235.73
-19.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.